Studies on Β-Sitosterol Liposome Encapsulation of Milk-Borne Bioactive Components

Jin-song CAO,Qin WANG,Zhong CHEN,Hong ZHU,Ying-ping ZUO,Lin-yan LV,Shao-min WU,Zheng-xiang NING
DOI: https://doi.org/10.3969/j.issn.1001-2230.2009.02.001
2009-01-01
Abstract:Human Insulin was encapsulated by soybean phosphatidyl choline and phytosterol liposomes in the thin film hydration.Subjected to CL-4B gel chromatography,liposomes separated from free proteins and the encapsulation rate could be determined.The conditions to obtain the higher encapsulation rate(53.8%) included: the mass rate of soybean phosphatidyl choline and β-sitosterol 1.75∶1,the Insulin concentration 2.0 mg.mL-1,preparation temperature 42.3 ℃.The microscopical observation and particle size analysis showed these liposomes were typical multil-amellar morphology with an average diameter of around 3.086 mm.The activity of encapsulated bioactive component survived better in mimic gastrointestinal digestive system than the free components.The liposomal products added in milk can survive pasteurization(63~65 ℃/30 min),showed excellent dispersion stability in the first 7 days during cold storage,however,the system destabilized and amalgamation of liposomal parti-cles happened after 8-9 days.This study suggested that β-sitosterol-phosphatidyl choline liposome had a potential to be used as a fortifying carrier of milk-borne bioactive components.
What problem does this paper attempt to address?